Antonio Virgilio Failla

Antonio Virgilio Failla

Auto-generated profile, based on publicly available information

Antonio Virgilio Failla

Microscopy Imaging Facility, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
SBSantra Brenna
Santra Brenna
HAHermann Altmeppen
Hermann Altmeppen
BMBehnam Mohammadi
Behnam Mohammadi
BRBjörn Rissiek
Björn Rissiek
FSFlorence Schlink
Florence Schlink
TMTim Magnus
Tim Magnus
Extracellular vesicles (EVs) are important means of intercellular communication and a potent tool for regenerative therapy. In ischaemic stroke, transient blockage of a brain artery leads to a lack of glucose and oxygen in the affected brain tissue, provoking neuronal death by necrosis in the core of the ischaemic region. The fate of neurons in the surrounding penumbra region depends on the stimuli, including EVs, received during the following hours. A detailed characterization of such stimuli is crucial not only for understanding stroke pathophysiology but also for new therapeutic interventions. In the present study, we characterize the EVs in mouse brain under physiological conditions and 24 h after induction of transient ischaemia in mice. We show that, in steady‐state conditions, microglia are the main source of small EVs (sEVs), whereas after ischaemia the main sEV population originates from astrocytes. Brain sEVs presented high amounts of the prion protein (PrP), which were further increased after stroke. Moreover, EVs were enriched in a proteolytically truncated PrP fragment (PrP‐C1). Because of similarities between PrP‐C1 and certain viral surface proteins, we studied the cellular uptake of brain‐derived sEVs from mice lacking (PrP‐KO) or expressing PrP (WT). We show that PrP‐KO‐sEVs are taken up significantly faster and more efficiently than WT‐EVs by primary neurons. Furthermore, microglia and astrocytes engulf PrP‐KO‐sEVs more readily than WT‐sEVs. Our results provide novel information on the relative contribution of brain cell types to the sEV pool in murine brain and indicate that increased release of sEVs by astrocytes together with elevated levels of PrP in sEVs may play a role in intercellular communication at early stages after stroke. In addition, amounts of PrP (and probably PrP‐C1) in brain sEVs seem to contribute to regulating their cellular uptake.

25 June 2012 in Applied Physics Letters
Verified
Journal Article
Closed access
FWFrank Wackenhut
Frank Wackenhut
AFAntonio Virgilio Failla
Antonio Virgilio Failla
TZTina Züchner
Tina Züchner
MSMathias Steiner
Mathias Steiner
AMAlfred J. Meixner
Alfred J. Meixner
We use raster-scanning confocal microscopy in combination with radially and azimuthally polarized laser excitation for mapping the three-dimensional (3D) orientation of individual spatially isolated gold nanorods (GNRs). The simultaneous acquisition of both the elastic scattering patterns and the one-photon luminescence patterns of the same GNR allows for determining both the particle position and the orientation with high precision. By analyzing experimental patterns and comparing them to theoretical results obtained by computer simulations, we establish a complete 3D photoluminescence map of single GNRs. Both elastic scattering and luminescence patterns of the same particle are found to display modifications of the refractive index of the dielectric environment. The polarization dependence of GNRs photoluminescence suggests a plasmon-mediated process.

15 August 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GWGuochao Wu
Guochao Wu
SLShuya Liu
Shuya Liu
JHJulia Hagenstein
Julia Hagenstein
MAMalik Alawi
Malik Alawi
FHFelicitas E. Hengel
Felicitas E. Hengel
THTobias B. Huber
Tobias B. Huber
Adeno-associated virus (AAV) is a promising in vivo gene delivery platform showing advantages in delivering therapeutic molecules to difficult or undruggable cells. However, natural AAV serotypes have insufficient transduction specificity and efficiency in kidney cells. Here, we developed an evolution-directed selection protocol for renal glomeruli and identified what we believe to be a new vector termed AAV2-GEC that specifically and efficiently targets the glomerular endothelial cells (GEC) after systemic administration and maintains robust GEC tropism in healthy and diseased rodents. AAV2-GEC–mediated delivery of IdeS, a bacterial antibody-cleaving proteinase, provided sustained clearance of kidney-bound antibodies and successfully treated antiglomerular basement membrane glomerulonephritis in mice. Taken together, this study showcases the potential of AAV as a gene delivery platform for challenging cell types. The development of AAV2-GEC and its successful application in the treatment of antibody-mediated kidney disease represents a significant step forward and opens up promising avenues for kidney medicine.

31 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MEMaha Elazezy
Maha Elazezy
SSSandra Schwentesius
Sandra Schwentesius
LSLuisa Stegat
Luisa Stegat
HWHarriet Wikman-Kocher
Harriet Wikman-Kocher
SWStefan Werner
Stefan Werner
SJSimon Joosse
Simon Joosse
Keratins are the main identification markers of circulating tumor cells (CTCs); however, whether their deregulation is associated with the metastatic process is largely unknown. Previously we have shown by in silico analysis that keratin 16 (KRT16) mRNA upregulation might be associated with more aggressive cancer. Therefore, in this study, we investigated the biological role and the clinical relevance of K16 in metastatic breast cancer. By performing RT-qPCR, western blot, and immunocytochemistry, we investigated the expression patterns of K16 in metastatic breast cancer cell lines and evaluated the clinical relevance of K16 expression in CTCs of 20 metastatic breast cancer patients. High K16 protein expression was associated with an intermediate mesenchymal phenotype. Functional studies showed that K16 has a regulatory effect on EMT and overexpression of K16 significantly enhanced cell motility (p < 0.001). In metastatic breast cancer patients, 64.7% of the detected CTCs expressed K16, which was associated with shorter relapse-free survival (p = 0.0042). Our findings imply that K16 is a metastasis-associated protein that promotes EMT and acts as a positive regulator of cellular motility. Furthermore, determining K16 status in CTCs provides prognostic information that helps to identify patients whose tumors are more prone to metastasize.

26 December 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TNTheresa Nauth
Theresa Nauth
FHFranziska Huschka
Franziska Huschka
MSMichaela Schweizer
Michaela Schweizer
JBJens Bernhard Bosse
Jens Bernhard Bosse
ADAndreas Diepold
Andreas Diepold
MAMartin Aepfelbacher
Martin Aepfelbacher
Type III secretion systems (T3SSs) are essential virulence factors of numerous bacterial pathogens. Upon host cell contact the T3SS machinery—also named injectisome—assembles a pore complex/translocon within host cell membranes that serves as an entry gate for the bacterial effectors. Whether and how translocons are physically connected to injectisome needles, whether their phenotype is related to the level of effector translocation and which target cell factors trigger their formation have remained unclear. We employed the superresolution fluorescence microscopy techniques Stimulated Emission Depletion (STED) and Structured Illumination Microscopy (SIM) as well as immunogold electron microscopy to visualize Y. enterocolitica translocons during infection of different target cell types. Thereby we were able to resolve translocon and needle complex proteins within the same injectisomes and demonstrate that these fully assembled injectisomes are generated in a prevacuole, a PI(4,5)P2 enriched host cell compartment inaccessible to large extracellular proteins like antibodies. Furthermore, the operable translocons were produced by the yersiniae to a much larger degree in macrophages (up to 25% of bacteria) than in HeLa cells (2% of bacteria). However, when the Rho GTPase Rac1 was activated in the HeLa cells, uptake of the yersiniae into the prevacuole, translocon formation and effector translocation were strongly enhanced reaching the same levels as in macrophages. Our findings indicate that operable T3SS translocons can be visualized as part of fully assembled injectisomes with superresolution fluorescence microscopy techniques. By using this technology, we provide novel information about the spatiotemporal organization of T3SS translocons and their regulation by host cell factors. Many human, animal and plant pathogenic bacteria employ a molecular machine termed injectisome to inject their toxins into host cells. Because injectisomes are crucial for these bacteria’s infectious potential they have been considered as targets for antiinfective drugs. Injectisomes are highly similar between the different bacterial pathogens and most of their overall structure is well established at the molecular level. However, only little information is available for a central part of the injectisome named the translocon. This pore-like assembly integrates into host cell membranes and thereby serves as an entry gate for the bacterial toxins. We used state of the art fluorescence microscopy to watch translocons of the diarrheagenic pathogen Yersinia enterocolitica during infection of human host cells. Thereby we could for the first time—with fluorescence microscopy—visualize translocons connected to other parts of the injectisome. Furthermore, because translocons mark functional injectisomes we could obtain evidence that injectisomes only become active for secretion of translocators when the bacteria are almost completely enclosed by host cells. These findings provide a novel view on the organization and regulation of bacterial translocons and may thus open up new strategies to block the function of infectious bacteria.

12 April 2023 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
NWNina Wolska
Nina Wolska
MCMeral Celikag
Meral Celikag
AFAntonio Virgilio Failla
Antonio Virgilio Failla
ATAnuradha Tarafdar
Anuradha Tarafdar
TRThomas Renné
Thomas Renné
GPGiordano Pula
Giordano Pula
Platelets contain high levels of amyloid β (Aβ) peptides and have been suggested to participate in the deposition of amyloid plaques in Alzheimer’s disease. This study aimed to determine whether human platelets release pathogenic Aβ peptides Aβ1-42 and Aβ1-40 and to characterize the mechanisms regulating this phenomenon. Enzyme-linked immunosorbent assays (ELISAs) and single platelet immunostaining were utilised to study the release and subcellular localisation of Aβ, respectively. ELISAs revealed that thrombin and the pro-inflammatory molecule lipopolysaccharide (LPS) induce platelet release of both Aβ1-42 and Aβ1-40. Notably, LPS preferentially induced the release of Aβ1-42, which was potentiated by the reduction of oxygen from atmospheric levels to physiological hypoxia. The selective β secretase (BACE) inhibitor LY2886721 showed no effect on the release of either Aβ1-40 or Aβ1-42 in our ELISA experiments. This suggested a store-and-release mechanism that was confirmed in immunostaining experiments showing co-localisation of cleaved Aβ peptides with platelet alpha granules. Taken together, our data suggest that human platelets release pathogenic Aβ peptides as a result of a store-and-release mechanism rather than a de novo proteolytic event. Although further studies are required to fully characterize this phenomenon, we suggest the possibility of a role for platelets in the deposition of Aβ peptides and the formation of amyloid plaques. Interestingly, the combination of hypoxia and inflammation that we simulated in vitro with reduced oxygen tension and LPS may increase the release of fibrillogenic Aβ1-42 and, consequently, exacerbate amyloid plaque deposition in the brain of patients with Alzheimer’s disease.